Autologous stem cell transplantation for T and null cell CD30-positive anaplastic large cell lymphoma: Analysis of 64 adult and paediatric cases reported to the European Group for Blood and Marrow Transplantation (EBMT)

Bone Marrow Transplantation

Volumn 23, Issue 5, 1999, Pages 437-442

  Fanin, R ^a   Ruiz De Elvira, M C ^b   Sperotto, A ^a   Baccarani, M ^a   Goldstone, A ^b  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Anaplastic large cell lymphoma; Autologous stem cell transplantation

Indexed keywords

CD30 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CHILD; FEMALE; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STEM CELL TRANSPLANTATION; SURVIVAL; T CELL LYMPHOMA;

EID: 0033013771     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701596     Document Type: Article

References (20)

1. Greer JP, Kinney MC, Collins RD et al. Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J Clin Oncol 1991; 9: 539-547.
2. Shulman LN, Frisard B, Antin JH et al. Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome. J Clin Oncol 1993; 11: 937-942.
3. Longo G, Federico M, Pieresca C et al. Anaplastic large cell lymphoma (CD30+/Ki-1+). Analysis of 35 cases followed at GISL centres. Eur J Cancer 1995; 31: 1763-1767.
4. Clavio M, Rossi E, Truini M et al. Anaplastic large cell lymphoma: a clinicopathologic study of 53 patients. Leuk Lymphoma 1996; 22: 319-327.
5. Filippa DA, Ladanyi M, Wollner N et al. CD30 (Ki-1)-positive malignant lymphomas: clinical, immunophenotypic, histologic, and genetic characteristics and differences with Hodgkin's disease. Blood 1996; 87: 2905-2917.
6. Zinzani PL, Bendandi M, Martelli M et al. Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients. J Clin Oncol 1996; 14: 955-962.
7. Tilly H, Gaulard P, Lepage E et al for the Groupe d'Etudes des Lymphomes de l'Adulte. Primary anaplastic large cell lymphoma in adults: clinical presentation, immunophenotype and outcome. Blood 1997; 9: 3727-3734.
8. Penny RJ, Blaustein JC, Longtine JA et al. Ki-Positive large cell lymphomas, a heterogeneous group of neoplasms. Cancer 1991; 68: 362-373.
9. Pileri S, Bocchia M, Baroni CD et al. Anaplastic large cell lymphoma (CD30+/Ki-1+): results of a prospective clinicopathological study of 69 cases. Br J Haematol 1994; 86: 513-523.
10. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
11. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma. Blood 1997; 89: 3909-3918.
12. Engelhard M, Brittinger G, Huhn D et al. Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor. Blood 1997; 89: 2291-2297.
13. Fanin R, Silvestri F, Geromin A et al. Primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma of the adult: sequential intensive treatment with the F-MACHOP regimen (± radiotherapy) and autologous bone marrow transplantaion. Blood 1996; 87: 1243-1248.
14. Fanin R, Silvestri F, Geromin A et al. Sequential intensive treatment with the F-MACHOP regimen (± radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma of the adults. Leuk Lymphoma 1997; 24: 369-377.
15. Oken MM, Creech RH, Tormey DC. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-655.
16. Kaplan JO, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457-481.
17. Cox DR. Regressions models and life tables. JR Stat Soc 1983; 34: 187-220.
18. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. New Engl J Med 1993; 14: 987-994.
19. Harris NL. Principles of the revised European-American lymphoma classification (from the International Lymphoma Study Group). Ann Oncol 1997; 8: 11-16.
20. Pettengell R, Radfod JA, Morenstern GR. Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma. J Clin Oncol 1996; 14: 586-592.